Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A.
The human cyclin Bl gene is cell cycle regulated with maximal activity during G(2)/M. We examined the role of histone deacetylation in cyclin Bl regulation using the histone deacetylase inhibitor trichostatin A (TSA). TSA treatment (100 ng/ml) of NIH3T3 cells containing the luciferase reporter construct pCycB(-287)-LUC caused an increase in promoter activity in G(0) and G(1) but no significant change in G(2). Removal of upstream sequences including an E-box and Sp1 site eliminated the TSA induced increase in G(0) and G(1), and caused a decrease in promoter activity during S and G(2). Promoter activity increased only 2-fold following TSA treatment of G(0) cells containing the construct pCycB(MUT-E-Box)-LUC with an E-box mutation, and a decrease in activity was detected during G(2). We conclude that histone deacetylation contributes to the repression of cyclin B1 expression in G(0) and G(1), and that this mechanism requires, in part, the E-box. TSA reduction of cyclin B1 promoter activity in G(2), however, involves sequences within the first 119 bp. A working model for cyclin B1 regulation is provided.
Katula
Karen S
KS
Department of Biology, University of North Carolina at Greensboro, P.O. Box 26174, Greensboro, NC 27402-6174, USA. kskatula@uncg.edu
Fields
Andrea
A
Apple
Philip
P
Rotruck
Todd
T
D016475:3T3 Cells; D000107:Acetylation; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects* / Q000235:genetics*; D019926:Cyclin B / Q000235:genetics*; D056744:Cyclin B1; D004791:Enzyme Inhibitors / Q000494:pharmacology; D016193:G1 Phase / Q000187:drug effects / Q000235:genetics; D016195:G2 Phase / Q000187:drug effects / Q000235:genetics; D005809:Genes, Regulator / Q000187:drug effects; D056572:Histone Deacetylase Inhibitors; D006657:Histones / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D051379:Mice; D008954:Models, Biological; D009154:Mutation; D011401:Promoter Regions, Genetic / Q000187:drug effects; D016192:Resting Phase, Cell Cycle / Q000187:drug effects / Q000235:genetics; D016196:S Phase / Q000187:drug effects / Q000235:genetics; D015854:Up-Regulation / Q000187:drug effects
C534699:CCNB1 protein, human; C534700:Ccnb1 protein, mouse; D019926:Cyclin B; D056744:Cyclin B1; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; C012589:trichostatin A